PBRM1 and nonpapillary renal cell carcinoma: Hakimi et al. investigated the impact of PBRM1 status in 609 patients with ccRCC from two different cohorts (MSKCC, n = 188 and TCGA, n = 421) showing no significant impact on CSS.